BRCA1 mutations and prostate cancer in Poland
Cezary Cybulski1, Bohdan Górski, Jacek Gronwald
1Department of Genetics and Pathology, International Hereditary Cancer Center, Poland. cezarycy@sci.pam.szczecin.pl
Summary
BRCA1 mutations show mixed results for prostate cancer risk. Specific mutations like 4153delA and C61G may increase risk, while 5382insC appears unrelated in the Polish population.
Area of Science:
- Genetics
- Oncology
- Epidemiology
Background:
- Evidence linking BRCA1 mutations to prostate cancer risk is inconsistent.
- BRCA1 gene mutations are associated with increased risk for several cancers, but their role in prostate cancer requires further clarification.
Purpose of the Study:
- To investigate the association between specific BRCA1 founder mutations and prostate cancer risk in the Polish population.
- To determine if inherited BRCA1 variations influence prostate cancer susceptibility.
Main Methods:
- Genotyping of 1793 Polish prostate cancer cases and 4570 controls for three BRCA1 founder mutations (C61G, 4153delA, 5382insC).
- Statistical analysis using odds ratios and confidence intervals to assess risk association.
Main Results:
- Overall BRCA1 mutation frequency was similar in cases (0.45%) and controls (0.48%).
- The 5382insC mutation was not associated with increased prostate cancer risk (OR=0.9).
- The 4153delA (OR=5.1) and C61G (OR=2.6) mutations showed a potential increased risk, particularly for familial prostate cancer (OR=12).
Conclusions:
- The BRCA1 5382insC mutation is unlikely to be pathogenic for prostate cancer in the Polish population.
- Other BRCA1 founder mutations (4153delA, C61G) may confer an increased risk of prostate cancer, especially familial forms.
- Prostate cancer risk in BRCA1 mutation carriers appears to be mutation-specific.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...